Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment,
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment,
Tesla’s stock is rallying as investors cheer a return of Elon Musk as a full-time CEO, and is fast approaching
American’s quarterly results beat forecasts but the profit view for the current quarter was on the downbeat side...
Cruise stocks have been falling, but J.P. Morgan says buy because there have been no signs of reduced demand despite
Tesla’s stock is sinking after another month of bad China sales. Elon Musk has now lost about $7 billion in
No posts found.